Apnimed, Inc.

APMD

Apnimed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, up 380.1% from fiscal 2024. Insiders bought in the last twelve months.

17.76 0.49 −2.68%
Market cap
$759.6M
P/E
0.9×
Fwd P/E
5.0×
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
0.00
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25
Total current assets
184.77 78.16 45.06
Total non-current assets
10.68 0.86 27.82
Total Assets
195.46 79.02 72.87
Total current liabilities
35.58 40.99 110.88
Total non-current liabilities
336.06 342.15 334.78
Total liabilities
371.64 383.14 445.66
Common Equity (Total)
(176.18) (304.12) (372.78)
Shareholders Equity (Total)
(176.18) (304.12) (372.78)
Total Debt
79.60 38.54 40.65

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 7 Oct 2026